(Q38089161)

28 August 2017

title

Towards the harmonization of outcome measures in children with mitochondrial disorders (English)

1 reference

28 August 2017

Saskia Koene

1

1 reference

28 August 2017

Merel Jansen

2

1 reference

28 August 2017

Chris M Verhaak

3

1 reference

28 August 2017

Remco L A De Vrueh

4

1 reference

28 August 2017

Imelda J M De Groot

5

1 reference

28 August 2017

Jan A M Smeitink

6

1 reference

28 August 2017

language of work or name

1 reference

12 March 2013

1 reference

Developmental Medicine and Child Neurology

28 August 2017

published in

1 reference

28 August 2017

volume

55

1 reference

28 August 2017

issue

8

1 reference

28 August 2017

page(s)

698-706

1 reference

The epidemiology of mitochondrial disorders--past, present and future

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Monogenic mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Molecular pathology of MELAS and L-arginine effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Outcomes in pediatric neurology: a review of conceptual issues and recommendationsThe 2010 Ronnie Mac Keith Lecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Endpoints in respiratory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

RETRACTED: Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD/ENMC Workshop on outcome measures, 12th–13th May 2007, Naarden, The Netherlands; TREAT-NMD Workshop on outcome measures in exper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FDMCN.12119

21 January 2018

Identifiers

DOI

10.1111/DMCN.12119

1 reference

28 August 2017

1 reference